AUGMENTATION OF THE STERILIZING EFFECT OF NEONATAL ANDROGENIZATION WITH TROPOLONE, A CATECHOL-O-METHYLTRANSFERASE INHIBITOR, IN FEMALE RATS

被引:4
|
作者
REZNIKOV, AG
NOSENKO, ND
TARASENKO, LV
机构
关键词
androgen; catechol-O-methyltransferase; catecholamines; hypothalamus; sexu al differentiation;
D O I
10.1159/000125628
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The influence of tropolone, a catechol-O-methyltransferase (COMT) inhibitor, on the sterilizing effect of neonatal testosterone propionate (TP) has been studied in Wistar female rats. Tropolone-induced changes in COMT activity and noradrenaline (NA) and dopamine (DA) contents in the hypothalamus have been evaluated. Inhibition of COMT activity was maximal 3 h after a single injection of 0.6 mg tropolone on postnatal day 5. An increase in DA level was observed 6 h after drug injection, whereas the NA content was elevated 24 h after tropolone administration. A sexual dimorphism in hypothalamic NA content in rats was found on postanatal day 10: it was higher in males than in females. The rise of catecholamines in the hypothalamus of 10-day-old female rats induced by COMT inhibition with tropolone (0.3 mg on postnatal days 5 and 7) was unable to masculinize developing neuroendocrine regions responsible for sexual cyclicity. At the same time, combined administration of tropolone (0.1 mg daily on postnatal days 4-10) and TP (0.025 mg on day 4) enhanced the sterilizing effect of the androgen. An anovulatory sterility appeared in all experimental animals. It is suggested that a cooperative interaction occurs between catecholamines and sex steroids as determinants of brain sexual differentiation.
引用
收藏
页码:455 / 459
页数:5
相关论文
共 50 条
  • [1] Beneficial effect of nitecapone, an antioxidant and inhibitor of catechol-O-methyltransferase on renal dysfunction in diabetic rats
    Körner, A
    Eklöf, AC
    Jaremko, G
    Lal, M
    DiBona, G
    Aperia, A
    DIABETOLOGIA, 1999, 42 : A275 - A275
  • [2] Salvianolic acid B as a substrate and weak catechol-O-methyltransferase inhibitor in rats
    Qi, Qu
    Cao, Lijuan
    Li, Feiyan
    Wang, Hong
    Liu, Huiying
    Hao, Haiping
    Hao, Kun
    XENOBIOTICA, 2015, 45 (09) : 820 - 827
  • [3] IDENTIFICATION OF MAJOR METABOLITES OF THE CATECHOL-O-METHYLTRANSFERASE INHIBITOR ENTACAPONE IN RATS AND HUMANS
    WIKBERG, T
    VUORELA, A
    OTTOILA, P
    TASKINEN, J
    DRUG METABOLISM AND DISPOSITION, 1993, 21 (01) : 81 - 92
  • [4] Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor
    Almeida, Luis
    Loureiro, Ana I.
    Vaz-da-Silva, Manuel
    Torrao, Leonel
    Maia, Joana
    Fernandes-Lopes, Carlos
    Falcao, Amilcar
    Igreja, Bruno
    Wright, Lyndon
    Soares-da-Silva, Patricio
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1097 - 1108
  • [5] Role of Catechol-O-Methyltransferase in the Disposition of Luteolin in Rats
    Chen, Zhongjian
    Chen, Meng
    Pan, Hao
    Sun, Siyuan
    Li, Liping
    Zeng, Su
    Jiang, Huidi
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (04) : 667 - 674
  • [6] PARADOXICAL EFFECT OF TUMOR INHIBITOR, VERNOLEPIN, ON CATECHOL-O-METHYLTRANSFERASE (COMT) ACTIVITY
    LANTZ, CH
    LARNER, J
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 556 - 556
  • [7] EFFECT OF ISOPROPYLNORMETADRENALINE AND A CATECHOL-O-METHYLTRANSFERASE INHIBITOR ON ADIPOSE TISSUE METABOLISM IN VITRO
    BJORNTORP, P
    CORRODI, H
    ACTA PHARMACOLOGICA ET TOXICOLOGICA, 1966, 24 (04): : 346 - +
  • [8] Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase
    Yao, JQ
    Li, Y
    Chang, MS
    Wu, HP
    Yang, XF
    Goodman, JE
    Liu, XM
    Liu, H
    Mesecar, AD
    van Breemen, RB
    Yager, JD
    Bolton, JL
    CHEMICAL RESEARCH IN TOXICOLOGY, 2003, 16 (05) : 668 - 675
  • [9] The equine metabolism of the catechol-O-methyltransferase enzyme inhibitor nitecapone
    Stanley, Shawn
    Deng, Derek
    Van den Berg, Koos
    Foo, Hsiao Ching
    DRUG TESTING AND ANALYSIS, 2022, 14 (05) : 929 - 935
  • [10] Metabolism and excretion of tolcapone, a novel inhibitor of catechol-O-methyltransferase
    Jorga, K
    Fotteler, B
    Heizmann, P
    Gasser, R
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 48 (04) : 513 - 520